Abstract:Background: At present, the commercial artificial small diameter (< 6 mm) vascular grafts are still unsatisfactory, due to poor biocompatibility and low long-term patency rate. Objective: This study was to design a novel tissue engineering blood vessel constructed by dog bone marrow derived endothelial progenitor cells and decellularized allogeneic vascular scaffolds. Design, time and setting: From December 2005 to December 2007, the experiment, a randomized control trial of cells an histopathology in vitro, was completed in the Affiliated Drum Tower Hospital of Nanjing University Medical School. Materials: The decellularized canine common carotids were obtained by a detergent-enzymatic procedure; Bone marrow mononuclear cells from mongrel adult dogs were isolated using density gradient centrifugation method and cultured in culture flasks coated with fibronectin. Subsequently, the expanded endothelial progenitor cells were seeded on the decellularized scaffolds, and then co-cultured in the self-made bioreactor to construct the tissue engineering blood vessels. Methods: Bilateral common carotid artery and lateral femoral artery in twenty dogs were all exposed. Three vascular segments from each dog were harvested and then randomly divided into three groups according to the transplant with the tissue engineering blood vessels, decellularized allogeneic vascular scaffolds or autogenous vein. Twenty vessels were implanted into the dogs of each group. Main outcome measures: Immunocytochemical staining was used to identify the cultured endothelial progenitor cells; After 6 months of transplantation, the grafts were retrieved for digital subtraction angiography, pathological test and scanning electron microscope examination. Results: Dog bone marrow mononuclear cells presented a cobblestone-like appearance at 10 days of the culture. The immunocytochemistry results were consistent with the phenotype of endothelial progenitor cells; After highly proliferative endothelial progenitor cells were seeded onto the decellularized scaffold for 10 days, seed cells attached well in the lumen of blood vessels; Six months after implantation, the tissue engineering blood vessels were 85% patent and autogenous vein grafts were 90 patent, which was superior to decellularized allogeneic vascular scaffolds (25%). Conclusion: This study provides a new strategy to develop a tissue engineering blood vessel with excellent biocompatibility and high patency rate by the co-culture of dog bone marrow derived endothelial progenitor cells with decellularized vascular scaffolds.

Successful Application of Biodegradable Vascular Scaffolds in the Dog Femoral Artery Transplantation

A New Method of Making Arterious Acellular Scaffold

Induction of Differentiation of CD34+ Cells in Vitro and Application in Endothelialization of Blood Vessel Prostheses

Tissue-engineered blood vessels constructed by bone marrow-derived endothelial progenitor cells and decellularized vascular scafflolds

Fabrication of heparinized small diameter TPU/PCL bi-layered artificial blood vessels and in vivo assessment in a rabbit carotid artery replacement model

Induction of Bone Marrow CD34+ Cells and Endothelialization of Polytetrafluoroethylene Prostheses.

Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.

Adhesion of endothelial cells with biodegradable polymer and basic fibroblast growth factor

[Constructing a Small-Diameter Decellularized Vascular Graft Pre-Loaded with Bfgf].

Morphological Study of Small-Caliber Hybrid Vascular Grafts Upon Replacement of Canine Common Carotid Arteries

Constructing small-caliber anticoagulant vascular grafts using decellularized scaffolds with heparin immobilization

Mechanically reinforced biotubes for arterial replacement and arteriovenous grafting inspired by architectural engineering

Hybrid Small-Diameter Vascular Grafts: Anti-expansion Effect of Electrospun Poly Ε-Caprolactone on Heparin-Coated Decellularized Matrices

Tissue Engineering of Small-Diameter Vascular Grafts by Endothelial Progenitor Cells Seeding Heparin-Coated Decellularized Scaffolds.

Development And In Vivo Evaluation Of Small-Diameter Vascular Grafts Engineered By Outgrowth Endothelial Cells And Electrospun Chitosan/Poly(Epsilon-Caprolactone) Nanofibrous Scaffolds

Preparation of PU/Fibrin Vascular Scaffold with Good Biomechanical Properties and Evaluation of Its Performance in vitro and in vivo

Fabrication and Evaluation of Tissue Engineering Vascular Scaffolds Based on Biodegradable Aliphatic–aromatic Copolyesters

Design and Comprehensive Assessment of a Biomimetic Tri-Layer Tubular Scaffold Via Biodegradable Polymers for Vascular Tissue Engineering Applications

Preliminary Study of in Vitro Construction of Small-Diameter Vascular Graft by Seeding Cells Onto Decellullarized Arterial Matrix

Development of small-diameter vascular grafts using PCL/PLA/gelatin/PVA/hyaluronic acid nanofibers containing VEGF/enoxaparin

Construction and performance evaluation of Hep/silk-PLCL composite nanofiber small-caliber artificial blood vessel graft